Neoadjuvant and Adjuvant Treatment Considerations of ILC | Lobular Breast Cancer Event 2023

[@clevelandclinic]

Make a gift to Lobular Breast Cancer. Your support can help us to build a brighter future in women’s health through innovative research and educational opportunities. Ways to give: cle.clinic/3Q3JYFF

[@SusanReik-r5o]

Thank you for this. I am an ILC survivor and always follow studies being done.

[@susanmacdonald5381]

Thanks to the Cleveland Clinic! The link above sends you to a dedicated fund to support research and treatment of Lobular Breast Cancer.

[@virginialaliberte2023]

This was extremely helpful! I have a patient with ILC high risk, had a recurrence on tamoxifen at 4 years and now 7 years on AI after that with no recurrence and her BCI showed exactly what you mentioned, that the recurrence score was high at 23%, but the predicted benefit of extended adjuvant endocrine therapy was NO, so we stopped it, because of adverse effects, but still wonder what else we could be doing to reduce that risk of a late recurrence. 😏

[@yorkiepeachygirlllc761]

Any information on the long term effectiveness of Tamoxifen on Invasive Lobular Cancer after a DMX for a post menopausal woman?

[@susanmacdonald5381]

Thanks to the Cleveland Clinic! The link above sends you to a dedicated fund to support research and treatment of Lobular Breast Cancer.